Scholars Central

Research articlePublished 20 May 2015

CSF Biomarkers: Low Amyloid-β 1-42 and BDNF and High IFN γ Differentiate Children Exposed to Mexico City High Air Pollution V Controls. Alzheimer's Disease Uncertainties

Authors: Lilian Calderón-Garcidueñas, Chih-kai Chao, Charles Thompson, Joel Rodriguez-Diaz, Maricela Franco-Lira, Partha S. Mukherjee, George Perry

The Center for Structural and Functional Neurosciences, University of Montana, Missoula, MT, USA; Escuela de Ciencias de la Salud, Universidad del Valle de México, Saltillo, Coahuila, México; Hospital Central Militar, Mexico City, Mexico; Department of Mathematics, Boise State University, Boise, Idaho, USA; College of Sciences, University of Texas at San Antonio, Texas, USA

Journal of Alzheimers Disease & Parkinsonism

Volume 5 · Issue 2 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: Long-term exposure to fine particulate matter (PM2.5) and ozone above US EPA standards is associated with increased risk of Alzheimer’s disease (AD). Mexico City Metropolitan Area (MCMA) children have prenatal and lifelong exposures to high PM2.5 and O3. MCMA children and young adults exhibit frontal tau hyperphosphorylation (40%) and amyloid-β diffuse plaques (51%) and a brain imbalance in genes involved in oxidative stress, inflammation, innate and adaptive immune responses. Methods: We measured total tau, tau phosphorylated at threonine 181, amyloid-β1-42 (Fujirebio,US), brain derived neurotrophic factor (BDNF), inflammatory mediators, insulin, and leptin in normal CSF samples from 56 MCMA and 26 control children age 11.9 ± 4.7 years. Results: Aβ 1-42 concentrations were lower in MCMA children (p=0.001) and correlated with cumulative PM2.5 (R2= 0.70). MCMA children had low BDNF (p=0.02) and high IFN-γ (p=0.0003) versus controls. In MCMA children, leptin correlated with insulin and MCP-1 (rs 0.34 and 0.41). Conclusion: Low Aβ1-42 in normal CSF samples from megacity children is a major finding given the interpretation of Aβ 1-42 in the temporal evolution of AD biomarkers. Low CSF Aβ, high IFN γ -detected in early AD and a key neuroinflammatory mediator in AD models-, and low BDNF strongly suggest deleterious CSF changes are evolving in 12 y olds, historically showing deficits in attention and short-term memory, information processing speed and executive function, plus olfactory, auditory and metabolic brain changes. Consideration for a shift in the preclinical AD paradigm is put forward in the setting of severe air pollution exposures. CSF children’s derangements involving Aβ 1-42, BDNF and IFN-γ and the potential discontinuity in the leptin central signaling pathway could be signifying a vicious downward spiral towards AD. We need to aim our efforts to the identification and mitigation of environmental factors influencing Alzheimer’s disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Lilian Calderón-Garcidueñas”
  • BylineArticles whose byline prints “Chih-kai Chao”
  • BylineArticles whose byline prints “Charles Thompson”
  • BylineArticles whose byline prints “Joel Rodriguez-Diaz”
  • BylineArticles whose byline prints “Maricela Franco-Lira”
  • BylineArticles whose byline prints “Partha S. Mukherjee”
  • BylineArticles whose byline prints “George Perry”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels